Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Legal Issues
Shire sues Teva regarding ANDA for generic versions of ADHD medicine in six doses
April 9th, 2006
Shire plc (SHP) announced that its subsidiary Shire Laboratories Inc. has filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. (Teva) for infringement of Shire Laboratories' U.S. Patent Nos. 6,322,819 (the '819 patent) and 6,605,300 (the '300 patent). The lawsuit results from an Abbreviated New Drug Application filed by Teva for generic versions of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg Adderall XR, pursuant to which Teva provided notice that it would seek to market its generic products before the expiration of the '819 and '300 Patents in 2018. The lawsuit...
Source: Medical Letter on the CDC & FDA (2006-04-09)
|
